Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
26.72
-0.36 (-1.33%)
Mar 5, 2026, 4:00 PM EST - Market closed
Immunovant Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Selling, General & Admin | 79.15 | 77.24 | 57.28 | 48.02 | 54.23 | 39.51 | |
| Research & Development | 408.02 | 360.92 | 212.93 | 160.26 | 101.81 | 68.6 | |
| Operating Expenses | 487.17 | 438.15 | 270.21 | 208.28 | 156.03 | 108.12 | |
| Operating Income | -487.17 | -438.15 | -270.21 | -208.28 | -156.03 | -108.12 | |
| Interest & Investment Income | 24.16 | 24.73 | 24.95 | 7.58 | - | - | |
| Other Non Operating Income (Expenses) | 2.45 | 0.47 | -1.01 | -0.25 | -0.78 | 0.33 | |
| EBT Excluding Unusual Items | -460.56 | -412.95 | -246.27 | -200.95 | -156.81 | -107.79 | |
| Pretax Income | -460.56 | -412.95 | -258.77 | -210.95 | -156.81 | -107.79 | |
| Income Tax Expense | 3.64 | 0.89 | 0.57 | 0.01 | -0.08 | -0.36 | |
| Net Income | -464.2 | -413.84 | -259.34 | -210.96 | -156.73 | -107.43 | |
| Net Income to Common | -464.2 | -413.84 | -259.34 | -210.96 | -156.73 | -107.43 | |
| Shares Outstanding (Basic) | 173 | 152 | 138 | 123 | 110 | 88 | |
| Shares Outstanding (Diluted) | 173 | 152 | 138 | 123 | 110 | 88 | |
| Shares Change (YoY) | 18.37% | 9.76% | 12.21% | 12.21% | 24.98% | 103.14% | |
| EPS (Basic) | -2.68 | -2.73 | -1.88 | -1.71 | -1.43 | -1.22 | |
| EPS (Diluted) | -2.68 | -2.73 | -1.88 | -1.71 | -1.43 | -1.22 | |
| Free Cash Flow | -423.09 | -376.63 | -214.59 | -188.39 | -106.37 | -83.54 | |
| Free Cash Flow Per Share | -2.44 | -2.48 | -1.55 | -1.53 | -0.97 | -0.95 | |
| EBITDA | -486.75 | -437.78 | -269.98 | -208.08 | -155.91 | -108.05 | |
| D&A For EBITDA | 0.42 | 0.38 | 0.23 | 0.19 | 0.13 | 0.07 | |
| EBIT | -487.17 | -438.15 | -270.21 | -208.28 | -156.03 | -108.12 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.